Rockwell Medical (RMTI) Adds Raymond Pratt, M.D., as Chief Medical Officer
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Join SI Premium – FREE
Rockwell Medical (Nasdaq: RMTI) has hired Raymond Pratt, M.D., as Chief Medical Officer. Dr. Pratt will oversee the clinical development and FDA regulatory process for Rockwell's Soluble Ferric Pyrophosphate (SFP) and manage all aspects of clinical research and development for SFP and new drug indications.
Prior to joining Rockwell, Dr. Pratt worked at Shire (Nasdaq: SHPGY) Pharmaceutical Development from 2003-2010, as Vice President R&D and the Scientific leader in the Emerging Business Unit and Renal Business Unit.
Prior to joining Rockwell, Dr. Pratt worked at Shire (Nasdaq: SHPGY) Pharmaceutical Development from 2003-2010, as Vice President R&D and the Scientific leader in the Emerging Business Unit and Renal Business Unit.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- J.M. Smucker names Jeff Varcoe as SVP of Science and Technical
- Robo.ai names Hao Wang of Changer.ae to its board of directors
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
